Cited by 341Cytokine Signaling Pathways and InteractionsHead and Neck Cancer StudiesNF-κB Signaling Pathways

The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.

Targeted inhibition of Stat3 with a decoy oligonucleotide abrogates head and neck cancer cell growth

Open access

Leong, Paul L., Andrews, Genevieve A., Johnson, Daniel E., Dyer, Kevin F., Xi, Sichuan, Mai, Jeffrey C., Robbins, Paul D., Gadiparthi, Seshu, Burke, Nancy A., Watkins, Simon F., Grandis, Jennifer Rubin·2003·Proceedings of the National Academy of Sciences

DOI 10.1073/pnas.0534764100PMC PMC153061

Open this paper in CoChat — free account

Abstract

The transcription factor signal transducer and activator of transcription 3 (Stat3) is constitutively activated in a variety of cancers including squamous cell carcinoma of the head and neck (SCCHN). Previous investigations have demonstrated that activated Stat3 contributes to a loss of growth control and transformation. To investigate the therapeutic potential of blocking Stat3 in cancer cells, we developed a transcription factor decoy to selectively abrogate activated Stat3. The Stat3 decoy was composed of a 15-mer double-stranded oligonucleotide, which corresponded closely to the Stat3 response element within the c-fos promoter. The Stat3 decoy bound specifically to activated Stat3 and blocked binding of Stat3 to a radiolabeled Stat3 binding element. By contrast, a mutated version of the decoy that differed by only a single base pair did not bind the activated Stat3 protein. Treatment of head and neck cancer cells with the Stat3 decoy inhibited proliferation and Stat3-mediated gene expression, but did not decrease the proliferation of normal oral keratinocytes. Thus, disruption of activated Stat3 by using a transcription factor decoy approach may serve as a novel therapeutic strategy for cancers characterized by constitutive Stat3 activation.

Integrity signals

Registry

Crossref · 10.1073/pnas.0534764100

Cites

47 of 47 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

STATs and Gene Regulation
Darnell, J. E. (1997) · Science · doi:10.1126/science.277.5332.1630 · Cited by 3,979
Stat3 as an Oncogene
Bromberg, J. F., Wrzeszczynska, M. H., Devgan, G., Zhao, Y., Pestell, R. G., Albanese, C., & Darnell, J. E. (1999) · Cell · doi:10.1016/s0092-8674(00)81959-5 · Cited by 2,790
STATs in oncogenesis
Bowman, T., Garcia, R., Turkson, J., & Jove, R. (2000) · Oncogene · doi:10.1038/sj.onc.1203527 · Cited by 1,743
Constitutive Activation of Stat3 Signaling Confers Resistance to Apoptosis in Human U266 Myeloma Cells
Catlett-Falcone, R., Landowski, T. H., Oshiro, M. M., Turkson, J., Levitzki, A., Savino, R., Ciliberto, G., Moscinski, L., Fernández-Luna, J. L., Nuñez, G., et al. (1999) · Immunity · doi:10.1016/s1074-7613(00)80011-4 · Cited by 1,638
The role of STATs in transcriptional control and their impact on cellular function
Bromberg, J., & Darnell, J. E. (2000) · Oncogene · doi:10.1038/sj.onc.1203476 · Cited by 1,201
Enhanced DNA-Binding Activity of a Stat3-Related Protein in Cells Transformed by the Src Oncoprotein
Yu, C.-L., Meyer, D. J., Campbell, G. S., Larner, A. C., Carter-Su, C., Schwartz, J., & Jove, R. (1995) · Science · doi:10.1126/science.7541555 · Cited by 931
A Specific Inhibitor of the Epidermal Growth Factor Receptor Tyrosine Kinase
Fry, D. W., Kraker, A. J., McMichael, A., Ambroso, L. A., Nelson, J. M., Leopold, W. R., Connors, R. W., & Bridges, A. J. (1994) · Science · doi:10.1126/science.8066447 · Cited by 806
Constitutive activation of Stat3 by the Src and JAK tyrosine kinases participates in growth regulation of human breast carcinoma cells
Garcia, R., Bowman, T. L., Niu, G., Yu, H., Minton, S., Muro‐Cacho, C., Cox, C. E., Falcone, R., Fairclough, R., Parsons, S. J., et al. (2001) · Oncogene · doi:10.1038/sj.onc.1204349 · Cited by 756
A common nuclear signal transduction pathway activated by growth factor and cytokine receptors.
Sadowski, H., Shuai, K., Darnell, J., & Gilman, M. (1993) · Science · doi:10.1126/science.8397445 · Cited by 682
Sustained Loss of a Neoplastic Phenotype by Brief Inactivation of MYC
Jain, M., Arvanitis, C., Chu, K., Dewey, W. C., Leonhardt, E. A., Trinh, M., Sundberg, C. D., Bishop, J. M., & Felsher, D. W. (2002) · Science · doi:10.1126/science.1071489 · Cited by 661

Show all 47 references

Research works printed but not linked: 8

T Kijima, H Niwa, R A Steinman, S D Drenning, W E Gooding, A L Wentzel, J Rubin Grandis Cell Growth Differ 13, 355–362 (2002).
B L Riser, R Mitra, D Perry, V Dixit, J Varani Cancer Res 49, 6123–6129 (1989).
D S Heo, C Snyderman, S M Gollin, S Pan, E Walker, R Deka, E L Barnes, J T Johnson, R B Herberman, T L Whiteside Cancer Res 49, 5167–5175 (1989).
H W Sharma, R Narayanan Anticancer Res 16, 589–596 (1996).
H W Sharma, J R Perez, K Higgins-Sochaski, R Hsiao, R Narayanan Anticancer Res 16, 61–69 (1996).
Y Sawa, R Morishita, K Suzuki, K Kagisaki, Y Kaneda, K Maeda, K Kadoba, H Matsuda Circulation 96,(Suppl.), II-280–II-284, ; discussion, II-285. (1997).
G Niu, R Heller, R Catlett-Falcone, D Coppola, M Jaroszeski, W Dalton, R Jove, H Yu Cancer Res 59, 5059–5063 (1999).
M Masuda, M Suzui, R Yasumatu, T Nakashima, Y Kuratomi, K Azuma, K Tomita, S Komiyama, I B Weinstein Cancer Res 62, 3351–3355 (2002).

Sorted by citations

Items 101–200 of 341

Inhibiting signal transducer and activator of transcription 3: rationality and rationale design of inhibitors
Mankan, A. K., & Greten, F. R. (2011) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2011.601739 · Cited by 77
Long-term Nicotine Exposure–Induced Chemoresistance Is Mediated by Activation of Stat3 and Downregulation of ERK1/2 via nAChR and Beta-Adrenoceptors in Human Bladder Cancer Cells
Chen, R.-J., Ho, Y., Guo, H., & Wang, Y. (2010) · Toxicological Sciences · doi:10.1093/toxsci/kfq028 · Cited by 75
Stat3-siRNA induces Fas-mediated apoptosis in vitro and in vivo in breast cancer
Rao (2009) · International Journal of Oncology · doi:10.3892/ijo_00000249 · Cited by 75
Targeting EGFR resistance networks in head and neck cancer
Ratushny, V., Astsaturov, I. A., Burtness, B. A., Golemis, E. A., & Silverman, J. S. (2009) · Cellular Signalling · doi:10.1016/j.cellsig.2009.02.021 · Cited by 76
Combined Targeting of Epidermal Growth Factor Receptor, Signal Transducer and Activator of Transcription-3, and Bcl-XL Enhances Antitumor Effects in Squamous Cell Carcinoma of the Head and Neck
Boehm, A. L., Sen, M., Seethala, R. S., Gooding, W. E., Freilino, M. L., Wong, S. M. Y., Wang, S., Johnson, D. E., & Grandis, J. R. (2008) · Molecular Pharmacology · doi:10.1124/mol.107.044636 · Cited by 74
Self-citation
STAT Signaling in Glioma Cells
Swiatek-Machado, K., & Kaminska, B. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-94-007-4719-7_10 · Cited by 74
Genome-wide screen identified let-7c/miR-99a/miR-125b regulating tumor progression and stem-like properties in cholangiocarcinoma
Lin, K.-Y., Ye, H., Han, B.-W., Wang, W.-T., Wei, P.-P., He, B., Li, X.-J., & Chen, Y.-Q. (2015) · Oncogene · doi:10.1038/onc.2015.396 · Cited by 71
Inhibition of Stat3 activation by sanguinarine suppresses prostate cancer cell growth and invasion
Sun, M., Liu, C., Nadiminty, N., Lou, W., Zhu, Y., Yang, J. C., Evans, C. P., Zhou, Q., & Gao, A. C. (2011) · The Prostate · doi:10.1002/pros.21409 · Cited by 72
NK Cells Are the Crucial Antitumor Mediators When STAT3-Mediated Immunosuppression Is Blocked in Hepatocellular Carcinoma
Sui, Q., Zhang, J., Sun, X., Zhang, C., Han, Q., & Tian, Z. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1302389 · Cited by 67
New Therapies in Head and Neck Cancer
Santuray, R. T., Johnson, D. E., & Grandis, J. R. (2018) · Trends in cancer · doi:10.1016/j.trecan.2018.03.006 · Cited by 67
Self-citation
Antiproliferative Mechanisms of a Transcription Factor Decoy Targeting Signal Transducer and Activator of Transcription (STAT) 3: The Role of STAT1
Lui, V. W. Y., Boehm, A. L., Koppikar, P., Leeman‐Neill, R. J., Johnson, D. E., Ogagan, M. J., Childs, E. E., Freilino, M. L., & Grandis, J. R. (2007) · Molecular Pharmacology · doi:10.1124/mol.106.032284 · Cited by 66
Self-citation
Targeting Blockage of STAT3 in Hepatocellular Carcinoma Cells Augments NK Cell Functions via Reverse Hepatocellular Carcinoma–Induced Immune Suppression
Sun, X., Sui, Q., Zhang, C., Tian, Z., & Zhang, J. (2013) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-12-1087 · Cited by 67
Deactivation of Signal Transducer and Activator of Transcription 3 Reverses Chemotherapeutics Resistance of Leukemia Cells via Down-Regulating P-gp
Zhang, X., Xiao, W., Wang, L., Tian, Z., & Zhang, J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020965 · Cited by 65
Abrogation of constitutive STAT3 activity sensitizes human hepatoma cells to TRAIL-mediated apoptosis
Kusaba, M., Nakao, K., Goto, T., Nishimura, D., Kawashimo, H., Shibata, H., Motoyoshi, Y., Taura, N., Ichikawa, T., Hamasaki, K., et al. (2007) · Journal of Hepatology · doi:10.1016/j.jhep.2007.04.017 · Cited by 63
Targeted inhibition of STATs and IRFs as a potential treatment strategy in cardiovascular disease
Szeląg, M., Piaszyk-Borychowska, A., Plens-Gałąska, M., Wesoły, J., & Bluyssen, H. A. R. (2016) · Oncotarget · doi:10.18632/oncotarget.9195 · Cited by 66
New strategies for immunosuppression: interfering with cytokines by targeting the Jak/Stat pathway
O’Shea, J. J., Park, H., Pesu, M., Borie, D. C., & Changelian, P. S. (2005) · Current Opinion in Rheumatology · doi:10.1097/01.bor.0000160781.07174.db · Cited by 63
Hepatitis D and hepatocellular carcinoma
Abbas, Z. (2015) · World Journal of Hepatology · doi:10.4254/wjh.v7.i5.777 · Cited by 67
HGF/c-met/Stat3 signaling during skin tumor cell invasion: indications for a positive feedback loop
Syed, Z., Yin, W., Hughes, K., Gill, J. N., Shi, R., & Clifford, J. L. (2011) · BMC Cancer · doi:10.1186/1471-2407-11-180 · Cited by 65
Manipulation of JAK/STAT Signalling by High-Risk HPVs: Potential Therapeutic Targets for HPV-Associated Malignancies
Morgan, E. L., & Macdonald, A. (2020) · Viruses · doi:10.3390/v12090977 · Cited by 64
Role of STAT3 in the initiation, progression, proliferation and metastasis of breast cancer and strategies to deliver JAK and STAT3 inhibitors
Dinakar, Y. H., Kumar, H., Mudavath, S. L., Jain, R., AJMEER, R., & Jain, V. K. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.120996 · Cited by 65
A STAT3-decoy oligonucleotide induces cell death in a human colorectal carcinoma cell line by blocking nuclear transfer of STAT3 and STAT3-bound NF-κB
Souissi, I., Najjar, I., Koon, L. A., Schischmanoff, P. O., Lesage, D., Coquil, S. L., Roger, C., Dusanter‐Fourt, I., Varin‐Blank, N., Cao, A., et al. (2011) · BMC Cell Biology · doi:10.1186/1471-2121-12-14 · Cited by 64
Blockage of the STAT3 signaling pathway with a decoy oligonucleotide suppresses growth of human malignant glioma cells
Gu, J., Li, G., Sun, T., Su, Y., Zhang, X., Shen, J., Tian, Z., & Zhang, J. (2008) · Journal of Neuro-Oncology · doi:10.1007/s11060-008-9590-9 · Cited by 62
Rapamycin targets STAT3 and impacts c-Myc to suppress tumor growth
Sun, L., Yan, Y., Lu, H., Li, J., Wang, Z., Wang, K., Wang, L., Li, Y., Jiang, H., & Zhang, Y. (2021) · Cell chemical biology · doi:10.1016/j.chembiol.2021.10.006 · Cited by 61
STAT3 inhibitor stattic enhances radiosensitivity in esophageal squamous cell carcinoma
Zhang, Q., Zhang, C., He, J., Guo, Q., Hu, D., Yang, X., Wang, J., Kang, Y., She, R., Wang, Z., et al. (2014) · Tumor Biology · doi:10.1007/s13277-014-2823-y · Cited by 61
Bortezomib up-regulates activated signal transducer and activator of transcription-3 and synergizes with inhibitors of signal transducer and activator of transcription-3 to promote head and neck squamous cell carcinoma cell death
Li, C., Zang, Y., Sen, M., Leeman‐Neill, R. J., Man, D., Grandis, J. R., & Johnson, D. E. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0327 · Cited by 60
Self-citation
Association of epidermal growth factor receptor (EGFR) gene copy number amplification with neck lymph node metastasis in areca-associated oral carcinomas
Chiang, W.-F., Liu, S.-Y., Yen, C.-Y., Lin, C.-N., Chen, Y.-C., Lin, S., & Chang, K. (2007) · Oral Oncology · doi:10.1016/j.oraloncology.2007.02.008 · Cited by 60
A STAT inhibitor patent review: progress since 2011
Lai, P., Rosa, D. A., Ali, A. M., Gómez‐Biagi, R. F., Ball, D. P., Shouksmith, A. E., & Gunning, P. T. (2015) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.2015.1086749 · Cited by 59
Conformationally Constrained Peptidomimetic Inhibitors of Signal Transducer and Activator of Transcription 3: Evaluation and Molecular Modeling
Mandal, P. K., Limbrick, D., Coleman, D. R., Dyer, G. A., Ren, Z., Birtwistle, J. S., Xiong, C., Chen, X., Briggs, J. M., & McMurray, J. S. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm801491w · Cited by 59
Role of STAT3 decoy oligodeoxynucleotides on cell invasion and chemosensitivity in human epithelial ovarian cancer cells
Zhang, X., Liu, P., Zhang, B., Wang, A., & Yang, M. (2010) · Cancer Genetics and Cytogenetics · doi:10.1016/j.cancergencyto.2009.10.004 · Cited by 59
Molecular Parameters of Head and Neck Cancer Metastasis
Bhave, S. L., Teknos, T. N., & Pan, Q. (2011) · Critical Reviews in Eukaryotic Gene Expression · doi:10.1615/critreveukargeneexpr.v21.i2.40 · Cited by 58
STAT3 Signaling and the Hyper-IgE Syndrome
Levy, D. E., & Loomis, C. A. (2007) · New England Journal of Medicine · doi:10.1056/nejme078197 · Cited by 60
Role of STAT3 in cancer cell epithelial‑mesenchymal transition (Review)
Zhang, G., Hou, S., Li, S., Wang, Y., & Cui, W. (2024) · International Journal of Oncology · doi:10.3892/ijo.2024.5636 · Cited by 58
Novel single-stranded oligonucleotides that inhibit signal transducer and activator of transcription 3 induce apoptosisin vitroandin vivoin prostate cancer cell lines
Barton, B. E., Murphy, T. F., Shu, P., Huang, H. F. S., Meyenhofen, M., & Barton, A. B. (2004) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.1183.3.10 · Cited by 55
STAT3 expression, activity and functional consequences of STAT3 inhibition in esophageal squamous cell carcinomas and Barrett’s adenocarcinomas
Timme, S., Ihde, S., Fichter, C. D., Waehle, V., Bogatyreva, L., Atanasov, K., Kohler, I., Schöpflin, A., Geddert, H., Faller, G., et al. (2013) · Oncogene · doi:10.1038/onc.2013.298 · Cited by 54
Targeting Antiapoptotic Bcl-2 Family Members with Cell-Permeable BH3 Peptides Induces Apoptosis Signaling, Death in Head, Neck Squamous Cell Carcinoma Cells
Li, R., Boehm, A. L., Miranda, M. B., Shangary, S. K., Grandis, J. R., & Johnson, D. E. (2007) · Neoplasia · doi:10.1593/neo.07394 · Cited by 54
Self-citation
Lack of toxicity of a STAT3 decoy oligonucleotide
Sen, M., Tosca, P. J., Zwayer, C., Ryan, M. J., Johnson, J. D., Knostman, K. A. B., Giclas, P. C., Peggins, J. O., Tomaszewski, J. E., McMurray, T. P., et al. (2009) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-008-0823-6 · Cited by 53
Self-citation
Signal Transducers and Activators of Transcription as Targets for Small Organic Molecules
Berg, T. (2008) · ChemBioChem · doi:10.1002/cbic.200800274 · Cited by 53
A New Perspective: Mitochondrial Stat3 as a Regulator for Lymphocyte Function
Rincón, M., & Pereira, F. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19061656 · Cited by 57
Immunohistochemical Analysis of Phosphotyrosine Signal Transducer and Activator of Transcription 3 and Epidermal Growth Factor Receptor Autocrine Signaling Pathways in Head and Neck Cancers and Metastatic Lymph Nodes
Seethala, R. R., Gooding, W. E., Handler, P. N., Collins, B. M., Zhang, Q. H., Siegfried, J. M., & Grandis, J. R. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1543 · Cited by 50
Self-citation
miR-21: A gene of dual regulation in breast cancer
Zhang, C., Liu, K., LI, T., Fang, J., Ding, Y., Sun, L., TU, T., JIANG, X., Du, S., Hu, J., et al. (2015) · International Journal of Oncology · doi:10.3892/ijo.2015.3232 · Cited by 52
New advances in molecular approaches to head and neck squamous cell carcinoma
Sahu, N., & Grandis, J. R. (2010) · Anti-Cancer Drugs · doi:10.1097/cad.0b013e32834249ba · Cited by 49
Self-citation
STAT1 and STAT3 in Tumorigenesis: Two Sides of the Same Coin?
Jr., R. H. B. (2009) · CRC Press eBooks · doi:10.1201/9781498713764-13 · Cited by 50
Signal Transducer and Activator of Transcription Protein 3 (STAT3): An Update on its Direct Inhibitors as Promising Anticancer Agents
Gelain, A., Mori, M., Meneghetti, F., & Villa, S. (2018) · Current Medicinal Chemistry · doi:10.2174/0929867325666180719122729 · Cited by 49
Transcription Factor Decoys: A New Model for Disease Intervention
Mann, M. J. (2005) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1359.021 · Cited by 49
Challenges in Clinical Design of Immunotherapy Trials for Malignant Glioma
Rolle, C. E., Sengupta, S., & Lesniak, M. S. (2009) · Neurosurgery Clinics of North America · doi:10.1016/j.nec.2009.08.002 · Cited by 48
Dysregulated STAT1-SOCS1 control of JAK2 promotes mammary luminal progenitor cell survival and drives ERα+ tumorigenesis
Chan, S. R., Rickert, C. G., Vermi, W., Sheehan, K. C. F., Arthur, C. D., Allen, J. A., White, J. M., Archambault, J. M., Lonardi, S., McDevitt, T. M., et al. (2013) · Cell Death and Differentiation · doi:10.1038/cdd.2013.116 · Cited by 47
IL-6 regulates MMP-10 expression via JAK2/STAT3 signaling pathway in a human lung adenocarcinoma cell line.
Zhang, X., Yin, P., Di, D., Luo, G., Zheng, L., Jiang, W., Zhang, J., Shi, Y., Zhang, J., & Xu, N. (2009) · PubMed · Cited by 48
Targeting STAT3 in Cancer with Nucleotide Therapeutics
Lau, Y.-T. K., Ramaiyer, M. S., Johnson, D. E., & Grandis, J. R. (2019) · Cancers · doi:10.3390/cancers11111681 · Cited by 49
Self-citation
Decoy oligodeoxynucleotide targeting activator protein-1 (AP-1) attenuates intestinal inflammation in murine experimental colitis
Moriyama, I., Ishihara, S., Rumi, M. A. K., Aziz, M., Mishima, Y., Oshima, N., Kadota, C., Kadowaki, Y., Amano, Y., & Kinoshita, Y. (2008) · Laboratory Investigation · doi:10.1038/labinvest.2008.38 · Cited by 48
Human Papillomavirus Infection in Head and Neck Squamous Cell Carcinomas: Transcriptional Triggers and Changed Disease Patterns
Aggarwal, N., Yadav, J., Thakur, K., Bibban, R., Chhokar, A., Tripathi, T., Bhat, A., Singh, T., Jadli, M., Singh, U., et al. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.537650 · Cited by 48
STAT3 is activated in a subset of the Ewing sarcoma family of tumours
Lai, R. L., Navid, F., Galindo, C. R., Liu, T., Fuller, C., Ganti, R., Dien, J., Dalton, J., Billups, C. A., & Khoury, J. (2006) · The Journal of Pathology · doi:10.1002/path.1941 · Cited by 47
Digesting the Role of JAK-STAT and Cytokine Signaling in Oral and Gastric Cancers
Ni, Y., Low, J. T., Silke, J., & O’Reilly, L. A. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.835997 · Cited by 47
Targeting the STAT3 pathway with STAT3 degraders
Wang, Z., Liao, X., He, H., Guo, X., & Chen, J. (2024) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2024.07.003 · Cited by 46
Targeting transcription factors for therapeutic benefit
Brennan, P., Donev, R., & Hewamana, S. (2008) · Molecular BioSystems · doi:10.1039/b801920g · Cited by 45
Crosstalk of the Androgen Receptor with Transcriptional Collaborators: Potential Therapeutic Targets for Castration-Resistant Prostate Cancer
Obinata, D., Takayama, K., Takahashi, S., & Inoue, S. (2017) · Cancers · doi:10.3390/cancers9030022 · Cited by 50
miR-515–5p suppresses HCC migration and invasion via targeting IL6/JAK/STAT3 pathway
Ni, J.-S., Zheng, H., Ou, Y.-L., Tao, Y., Wang, Z., Song, L., Yan, H.-L., & Zhou, W. (2020) · Surgical Oncology · doi:10.1016/j.suronc.2020.03.003 · Cited by 45
The Current State of Head and Neck Cancer Gene Therapy
Thomas, S. M., & Grandis, J. R. (2009) · Human Gene Therapy · doi:10.1089/hum.2009.163 · Cited by 43
Self-citation
Synthetic protein-binding DNA sponge as a tool to tune gene expression and mitigate protein toxicity
Wan, X., Pinto, F., Yu, L., & Wang, B. (2020) · Nature Communications · doi:10.1038/s41467-020-19552-9 · Cited by 43
A Single Decoy Oligodeoxynucleotides Targeting Multiple Oncoproteins Produces Strong Anticancer Effects
Gao, H., Xiao, J., Sun, Q., Lin, H., Bai, Y., Yang, L., Yang, B., Wang, H., & Wang, Z. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.024273 · Cited by 43
A STAT3-inhibitory hairpin decoy oligodeoxynucleotide discriminates between STAT1 and STAT3 and induces death in a human colon carcinoma cell line
Souissi, I., Ladam, P., Cognet, J. A. H., Coquil, S. L., Varin‐Blank, N., Baran‐Marszak, F., Metelev, V., & Fagard, R. (2012) · Molecular Cancer · doi:10.1186/1476-4598-11-12 · Cited by 43
Mechanistic insights and the clinical prospects of targeted therapies for glioblastoma: a comprehensive review
Shen, Y., Thng, D. K. H., Wong, A. L. A., & Toh, T. B. (2024) · Experimental Hematology and Oncology · doi:10.1186/s40164-024-00512-8 · Cited by 47
Applying Small Molecule Signal Transducer and Activator of Transcription-3 (STAT3) Protein Inhibitors as Pancreatic Cancer Therapeutics
Arpin, C. C., Mac, S., Jiang, Y., Cheng, H., Grimard, M., Page, B. D. G., Kamocka, M. M., Haftchenary, S., Su, H., Ball, D. P., et al. (2016) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-15-0003 · Cited by 42
STAT3 Cyclic Decoy Demonstrates Robust Antitumor Effects in Non–Small Cell Lung Cancer
Njatcha, C., Farooqui, M., Kornberg, A. E., Johnson, D. E., Grandis, J. R., & Siegfried, J. M. (2018) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-17-1194 · Cited by 41
Self-citation
Targeting cancer stem cells in medulloblastoma by inhibiting AMBRA1 dual function in autophagy and STAT3 signalling
Nazio, F., Pò, A., Abballe, L., Ballabio, C., Diomedi‐Camassei, F., Bordi, M., Camera, A., Caruso, S., Caruana, I., Pezzullo, M., et al. (2021) · Acta Neuropathologica · doi:10.1007/s00401-021-02347-7 · Cited by 40
STAT3-decoy oligodeoxynucleotide inhibits the growth of human lung cancer via down-regulating its target genes
Zhang, X., Zhang, J., Wei, H., & Tian, Z. (2007) · Oncology Reports · doi:10.3892/or.17.6.1377 · Cited by 42
STAT3: Key targets of growth-promoting receptor positive breast cancer
Jiang, R., Zhu, J., Zhang, H., Yuan, Y. J., Dong, Z.-X., Zhou, H., & Wang, X. (2024) · Cancer Cell International · doi:10.1186/s12935-024-03541-9 · Cited by 43
Seeing the Future of Cancer-Associated Transcription Factor Drug Targets
Konstantinopoulos, P. A. (2011) · JAMA · doi:10.1001/jama.2011.727 · Cited by 40
Transfer of suppressor of cytokine signaling 3 by an oncolytic adenovirus induces potential antitumor activities in hepatocellular carcinoma
Cui, Q., Jiang, W., Wang, Y., Lv, C., Luo, J., Zhang, W., Lin, F., Yin, Y., Cai, R., Wei, P., et al. (2007) · Hepatology · doi:10.1002/hep.21951 · Cited by 43
Suppression of tumor invasion and migration in breast cancer cells following delivery of siRNA against Stat3 with the antimicrobial peptide PR39
Tian, W., Li, B., Zhang, X., Dang, W., Wang, X., Tang, H., Wang, L., Cao, H., & Chen, T. (2012) · Oncology Reports · doi:10.3892/or.2012.1911 · Cited by 40
Knockdown of Stat3 expression using RNAi inhibits growth of laryngeal tumors in vivo
Gao, L., Wen, L., Yu, H. Q., Zhang, L., Meng, Y., Shao, Y., Xu, D.-Q., & Zhao, X. (2006) · Acta Pharmacologica Sinica · doi:10.1111/j.1745-7254.2006.00277.x · Cited by 40
Nucleic acid-based approaches to STAT inhibition
Sen, M., & Grandis, J. R. (2012) · JAK-STAT · doi:10.4161/jkst.22312 · Cited by 42
Self-citation
Overexpression of GRIM-19 in Cancer Cells Suppresses STAT3-Mediated Signal Transduction and Cancer Growth
Okamoto, T., Inozume, T., Mitsui, H., Kanzaki, M., Harada, K., Shibagaki, N., & Shimada, S. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-1147 · Cited by 38
Systemic Administration of a Cyclic Signal Transducer and Activator of Transcription 3 (STAT3) Decoy Oligonucleotide Inhibits Tumor Growth without Inducing Toxicological Effects
Sen, M., Paul, K. C., Freilino, M. L., Li, H., Li, C., Johnson, D. E., Wang, L., Eiseman, J. L., & Grandis, J. R. (2013) · Molecular Medicine · doi:10.2119/molmed.2013.00104 · Cited by 38
Self-citation
ZIC2 is downregulated and represses tumor growth via the regulation of STAT3 in breast cancer
Liu, Z., Chen, M., Zhang, Q., Zhang, Y., An, X., Luo, Y., Liu, X., Liu, S., Liu, Q., Yang, T., et al. (2020) · International Journal of Cancer · doi:10.1002/ijc.32922 · Cited by 38
CADPE suppresses cyclin D1 expression in hepatocellular carcinoma by blocking IL-6-induced STAT3 activation.
Won, C., Lee, C. S., Lee, J., Kim, T., Lee, K., Yang, Y. M., Kim, Y.-N., Ye, S., & Chung, M. (2010) · PubMed · Cited by 37
Crocin promotes apoptosis of human skin cancer cells by inhibiting the JAK/STAT pathway
Wang, G., Zhang, B., Wang, Y., Han, S., & Wang, C. (2018) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2018.6865 · Cited by 37
Retracted
Search for novel STAT3-dependent genes reveals SERPINA3 as a new STAT3 target that regulates invasion of human melanoma cells
Kulesza, D. W., Ramji, K., Maleszewska, M., Mieczkowski, J., Dąbrowski, M., Chouaı̈b, S., & Kaminska, B. (2019) · Laboratory Investigation · doi:10.1038/s41374-019-0288-8 · Cited by 37
Large Granular Lymphocyte Leukemia: From Dysregulated Pathways to Therapeutic Targets
LeBlanc, F., Zhang, D., Liu, X., & Loughran, T. P. (2012) · Future Oncology · doi:10.2217/fon.12.75 · Cited by 38
Inhibitory effects of decoy-ODN targeting activated STAT3 on human glioma growth in vivo.
Shen, J., Li, R., & Li, G. (2009) · PubMed · Cited by 36
Characterization of STAT3 expression, signaling and inhibition in feline oral squamous cell carcinoma
Brown, M. E., Bear, M. D., Rosol, T. J., Premanandan, C., Kisseberth, W. C., & London, C. A. (2015) · BMC Veterinary Research · doi:10.1186/s12917-015-0505-7 · Cited by 35
Cell-cell and cell-matrix adhesion in survival and metastasis: Stat3 versus Akt
Niit, M., Hoskin, V., Carefoot, E., Geletu, M., Arulanandam, R., Elliott, B. E., & Raptis, L. H. (2015) · BioMolecular Concepts · doi:10.1515/bmc-2015-0022 · Cited by 35
Structural basis for the binding of high affinity phosphopeptides to Stat3
McMurray, J. S. (2007) · Biopolymers · doi:10.1002/bip.20901 · Cited by 35
Cross-talk between Phospho-STAT3 and PLCγ1 Plays a Critical Role in Colorectal Tumorigenesis
Zhang, P., Zhao, Y., Zhu, X., Sedwick, D., Zhang, X., & Wang, Z. (2011) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-11-0147 · Cited by 34
STAT transcription factors in normal and cancer stem cells.
Dorritie, K., Redner, R., & Johnson, D. E. (2014) · Advances in Biological Regulation · doi:10.1016/j.jbior.2014.05.004 · Cited by 34
Self-citation
STAT3 as a therapeutic target for Epstein-Barr virus (EBV) – associated nasopharyngeal carcinoma
Ho, Y., Tsao, S., Zeng, M., & Lui, V. W. Y. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.11.052 · Cited by 36
Dietary compounds as potent inhibitors of the signal transducers and activators of transcription (STAT) 3 regulatory network
Trécul, A., Morceau, F., Dicato, M. A., & Diederich, M. F. (2012) · Genes & Nutrition · doi:10.1007/s12263-012-0281-y · Cited by 36
Current and Emerging Molecular Therapies for Head and Neck Squamous Cell Carcinoma
Kordbacheh, F., & Farah, C. S. (2021) · Cancers · doi:10.3390/cancers13215471 · Cited by 34
Hepatitis delta virus induces specific DNA methylation processes in Huh‐7 liver cancer cells
Benegiamo, G., Vinciguerra, M., Guarnieri, V., Niro, G. A., Andriulli, A., & Pazienza, V. (2013) · FEBS Letters · doi:10.1016/j.febslet.2013.03.021 · Cited by 33
Transcription factor decoy: a pre-transcriptional approach for gene downregulation purpose in cancer
Rad, S. M. A. H., Langroudi, L., Kouhkan, F., Yazdani, L., Koupaee, A. N., Asgharpour, S., Shojaei, Z., Bamdad, T., & Arefian, E. (2015) · Tumor Biology · doi:10.1007/s13277-015-3344-z · Cited by 34
Potential use of STAT3 inhibitors in targeted prostate cancer therapy: future prospects
Barton, B. E., & Barton, B. E. (2012) · OncoTargets and Therapy · doi:10.2147/ott.s32559 · Cited by 32
Regulation of transcription factors via natural decoys in genomic DNA
Kemme, C. A., Nguyen, D., Chattopadhyay, A., & Iwahara, J. (2016) · Transcription · doi:10.1080/21541264.2016.1188873 · Cited by 31
Silencing of the transcription factor STAT3 sensitizes lung cancer cells to DNA damaging drugs, but not to TNFα- and NK cytotoxicity
Kulesza, D. W., Carré, T., Chouaı̈b, S., & Kaminska, B. (2012) · Experimental Cell Research · doi:10.1016/j.yexcr.2012.11.005 · Cited by 31
New Insights into the Roles of ncRNA in the STAT3 Pathway
Zhang, J., Zhang, A., Wang, Y., Liu, N., You, Y., Kang, C., & Pu, P. (2012) · Future Oncology · doi:10.2217/fon.12.52 · Cited by 31
Silencing of COPB2 inhibits the proliferation of gastric cancer cells and induces apoptosis via suppression of the RTK signaling pathway
An, C., Liu, X., Zhang, X., Wang, J., Qiang, Y., Ye, X., Li, Q., Guan, Q., & Zhou, Y. (2019) · International Journal of Oncology · doi:10.3892/ijo.2019.4717 · Cited by 30
The Expression of p-STAT3 in Stage IV Melanoma: Risk of CNS Metastasis and Survival
Lee, I. Y., Fox, P. S., Ferguson, S. D., Bassett, R., Kong, L., Schacherer, C. W., Gershenwald, J. E., Grimm, E. A., Fuller, G. N., & Heimberger, A. B. (2012) · Oncotarget · doi:10.18632/oncotarget.475 · Cited by 29
Manipulating and understanding antibiotic production in Streptomyces coelicolor A3(2) with decoy oligonucleotides
McArthur, M., & Bibb, M. J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0710724105 · Cited by 29
Inhibitory effects of STAT3 decoy oligodeoxynucleotides on human epithelial ovarian cancer cell growth in vivo
Zhang, X., Liu, P., Zhang, B., Mao, H., Shen, L., & Ma, Y. (2013) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2013.1431 · Cited by 29
Genomic dissection of the cytokine-controlled STAT5 signaling network in liver
Hosui, A., & Hennighausen, L. G. (2008) · Physiological Genomics · doi:10.1152/physiolgenomics.00048.2008 · Cited by 29
Expression of Activated and Latent Signal Transducer and Activator of Transcription 3 in 303 Non–Small Cell Lung Carcinomas and 44 Malignant Mesotheliomas: Possible Role for Chemotherapeutic Intervention
Achcar, R. D., Cagle, P. T., & Jagirdar, J. S. (2007) · Archives of Pathology & Laboratory Medicine · doi:10.5858/2007-131-1350-eoaals · Cited by 29
Regulation of Neural Stem Cell Differentiation by Transcription Factors HNF4-1 and MAZ-1
Wang, J., Cheng, H., Li, X., Lü, W., Wang, K., & Wen, T. (2012) · Molecular Neurobiology · doi:10.1007/s12035-012-8335-0 · Cited by 28

Authors: Leong, P. L., Andrews, G. A., Johnson, D. E., Dyer, K. F., Xi, S., Mai, J. C., Robbins, P. D., Gadiparthi, S., Burke, N. A., Watkins, S. F., & Grandis, J. R.
Affiliations: University of Pittsburgh (US)
Departments of Otolaryngology, Medicine, Pharmacology, Molecular Genetics and Biochemistry, and Cell Biology and Physiology, University of Pittsburgh School of Medicine and University of Pittsburgh Cancer Institute, Pittsburgh, PA 15260
ORCID: Johnson, Daniel E.
Robbins, Paul D.
Venue: Proceedings of the National Academy of Sciences
Publisher: National Academy of Sciences
Published: 2003-03-14
Volume: 100
Issue: 7
Pages: 4138-4143
ISSN: 0027-8424 (ISSN-L)
1091-6490
DOI: 10.1073/pnas.0534764100
PMC: PMC153061
OpenAlex: W2143812692
Cited by: 340
References: 47
Citations by year: 2026: 5 · 2025: 4 · 2024: 13 · 2023: 11 · 2022: 6 · 2021: 8 · 2020: 13 · 2019: 14 · 2018: 10 · 2017: 3 · 2016: 8 · 2015: 20 · 2014: 16 · 2013: 23 · 2012: 25
FWCI: 7.21
Type: journal article
Language: en
Open access: green
europepmc.org
Locations: Proceedings of the National Academy of Sciences (publishedVersion)
Europe PMC (PubMed Central) (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Funders: Howard Hughes Medical Institute
American Academy of Otolaryngology-Head and Neck Surgery
National Institutes of Health
National Cancer Institute (CA77308, R01CA077308)
Topics: Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
Health Sciences › Medicine › Otorhinolaryngology › Head and Neck Cancer Studies
Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
Keywords: STAT3, transcription factor decoy, head and neck squamous cell carcinoma, c-fos promoter, constitutive STAT3 activation, tumor cell proliferation, oral keratinocytes
MeSH terms: Carcinoma, Squamous Cell, Cell Division, DNA-Binding Proteins, Head and Neck Neoplasms, Humans, Luciferases, Tumor Cells, Cultured, Trans-Activators, Apoptosis, Proto-Oncogene Proteins c-bcl-2, Oligodeoxyribonucleotides, Antisense, STAT3 Transcription Factor, bcl-X Protein

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Targeted inhibition of Stat3 with a decoy oligonucleotide abrogates head and neck cancer cell growth

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks